文献速递鼻科耳科与耳神经

慢性鼻窦炎中的咽鼓管功能障碍(ETD)与原发性ETD的比较:系统综述与Meta分析

Eustachian tube dysfunction (ETD) in chronic rhinosinusitis with comparison to primary ETD: A systematic review and meta-analysis.
PubMed 文献 · Int Forum Allergy Rhinol · 2022-01-05

该系统综述与Meta分析纳入16项研究,比较慢性鼻窦炎(CRS)合并咽鼓管功能障碍(ETD)与原发性ETD的ETDQ-7评分及治疗结局。在CRS患者中约半数存在ETD,CRS+ETD的基线ETDQ-7评分低于原发性ETD;单纯内镜鼻窦手术(ESS)治疗CRS+ETD后ETDQ-7评分平均变化-7.4,与原发性ETD经咽鼓管球囊扩张(ETBD)后的变化-13.9相似。

要点

  • 在CRS患者中,有具体数据的研究显示225例(47.2%)ETDQ-7评分>14.5,符合ETD。
  • CRS+ETD基线ETDQ-7评分为20.7±8.4,原发性ETD为29.5±8.1,后者显著更高(p<0.0001)。
  • 单纯ESS治疗CRS+ETD后ETDQ-7评分平均变化-7.4(95%CI -10.82至-3.99),与原发性ETD经ETBD后的-13.9(95%CI -18.01至-9.88)结局相似。

核心结论

  • ETD见于约半数CRS患者,单纯ESS治疗CRS+ETD的结局与原发性ETD经ETBD治疗的结局相似。

研究设计与样本

  • 遵循PRISMA进行系统检索PubMed、CINAHL、Scopus和Cochrane Library,纳入描述CRS中ETD的任何研究;原发性ETD研究限于仅用咽鼓管球囊扩张(ETBD)治疗且有术前和术后ETDQ-7评分者。
  • 共纳入16项研究:9项研究含1336例连续CRS患者,7项研究含161例原发性ETD患者。

主要发现

  • 在有具体数据的研究中,225例(47.2%)CRS患者ETDQ-7评分>14.5,符合ETD。
  • CRS+ETD基线ETDQ-7平均±标准差为20.7±8.4,不因息肉状态而异。
  • 原发性ETD平均ETDQ-7评分为29.5±8.1,显著高于CRS+ETD(p<0.0001)。
  • 单纯ESS治疗CRS+ETD后ETDQ-7均值在正常范围(13.2±5.3),平均变化-7.4(95%CI -10.82至-3.99)(p<0.00001)。
  • 原发性ETD经ETBD治疗后ETDQ-7评分为14.9±7.5,平均变化-13.9(95%CI -18.01至-9.88),p<0.00001。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Otologic symptoms consistent with Eustachian tube dysfunction (ETD) are common in patients with chronic rhinosinusitis (CRS), but can also occur independently of CRS as primary ETD. It is unclear if CRS+ETD is similar to primary ETD or how treatment outcomes compare. METHODS: A systematic search of PubMed, CINAHL, Scopus, and Cochrane Library was conducted following Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA). Any study describing ETD in CRS was included. Primary ETD studies were limited to those with preoperative and postoperative Eustachian Tube Dysfunction Questionnaire (ETDQ-7) scores in ETD treated only with Eustachian tube balloon dilation (ETBD). RESULTS: Sixteen studies were included: nine studies with 1336 consecutive patients with CRS and seven studies with 161 patients with primary ETD. In studies with specific data, 225 (47.2%) patients with CRS had a score >14.5, consistent with ETD. In CRS+ETD, baseline mean ± standard deviation (SD) ETDQ-7 score was 20.7 ± 8.4 and did not differ by polyp status. In primary ETD, mean ETDQ-7 score was significantly higher than CRS+ETD (29.5 ± 8.1, p < 0.0001). Regarding treatment outcomes, CRS+ETD treated with endoscopic sinus surgery (ESS) alone resulted in mean ETDQ-7 in the normal range (13.2 ± 5.3), with a mean change of -7.4 (95% confidence interval [CI], -10.82 to -3.99) (p < 0.00001). Patients with primary ETD treated with ETBD had postoperative ETDQ7 scores of 14.9 ± 7.5 with mean change of -13.9 (95% CI, -18.01 to -9.88), p < 0.00001. CONCLUSION: ETD is noted in approximately half of patients with CRS. Outcomes of CRS+ETD treated with ESS alone are similar to those of patients with primary ETD treated with ETBD.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Chen T, Shih MC, Edwards TS, et al. Eustachian tube dysfunction (ETD) in chronic rhinosinusitis with comparison to primary ETD: A systematic review and meta-analysis. Int Forum Allergy Rhinol. 2022. PMID: 34919345. doi:10.1002/alr.22942

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。